Biotech

All Articles

Sanofi's $80M bet on Fulcrum dystrophy medicine ends in period 3 go bust

.Only 4 months after Sanofi bet $80 thousand in beforehand cash money on Fulcrum Rehabs' losmapimod,...

Oncternal assets sinks 60% surrounded by layoffs, trial terminations

.Cancer company Oncternal Therapeutics is folding all its scientific tests and giving up staff, tran...

Roche is holding out chances that its own injectable obesity possibility can at some point display 25% fat loss in late-stage trial

.Roche is holding out chances that its own injectable excessive weight prospect can inevitably displ...

Novo Nordisk barrages 'exceptional' weight management result for dual-acting dental drug in very early test

.Novo Nordisk has lifted the cover on a stage 1 trial of its dental amylin and GLP-1 receptor co-ago...

AbbVie sues BeiGene over blood cancer medicine classified information

.Simply a handful of quick weeks after winning an FDA Fast Track tag for its own investigational BTK...

Lilly delivers one-two punch along with second tranche of beneficial information on every week the hormone insulin candidate

.Quickly after a positive information reduce for Eli Lilly's efsitora alfa, the Indianapolis-based b...

BridgeBio cuts gene therapy finances as medical data dissatisfy

.BridgeBio Pharma is actually lowering its own genetics therapy budget plan and pulling back coming ...

GSK gives up HSV vaccination really hopes after phase 2 fail, yielding race to Moderna, BioNTech

.GSK's attempt to cultivate the very first vaccine for genital herpes simplex infection (HSV) has en...

GSK's long-acting asthma medication cut in half assaults in period 3

.GSK's long-acting breathing problem procedure has been actually revealed to halve the variety of st...

AstraZeneca, Daiichi unbox Dato-DXd's general survival neglect

.AstraZeneca as well as Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has fallen sho...